Found: 22
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 3, doi. 10.1111/bjh.17589
- Publication type:
- Article
Gelatinous transformation of the bone marrow in a previously healthy male presenting with pancytopenia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 7, doi. 10.1111/bjh.18007
- By:
- Publication type:
- Article
Novel PDGFRA mutation in blastic plasmacytoid dendritic cell neoplasm; possible therapeutic implications.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 8, doi. 10.1111/bjh.18008
- By:
- Publication type:
- Article
BCR::ABL1 transcripts and clinical outcome ‐ interrogating the technique.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 9, doi. 10.1111/bjh.18046
- Publication type:
- Article
COVID‐19 vaccine response in chronic lymphocytic leukaemia is more than just seroconversion.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 11, doi. 10.1111/bjh.18047
- Publication type:
- Article
B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 13, doi. 10.1111/bjh.17879
- By:
- Publication type:
- Article
Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 28, doi. 10.1111/bjh.17904
- By:
- Publication type:
- Article
COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 41, doi. 10.1111/bjh.18014
- By:
- Publication type:
- Article
Assessment of quantitative polymerase chain reaction for BCR–ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 52, doi. 10.1111/bjh.18026
- By:
- Publication type:
- Article
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 63, doi. 10.1111/bjh.18051
- By:
- Publication type:
- Article
Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 71, doi. 10.1111/bjh.18054
- By:
- Publication type:
- Article
Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 76, doi. 10.1111/bjh.17992
- By:
- Publication type:
- Article
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 82, doi. 10.1111/bjh.18025
- By:
- Publication type:
- Article
Pharmacologic induction of PGC‐1α stimulates fetal haemoglobin gene expression.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 97, doi. 10.1111/bjh.18042
- By:
- Publication type:
- Article
Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e1, doi. 10.1111/bjh.18001
- By:
- Publication type:
- Article
Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e5, doi. 10.1111/bjh.17997
- By:
- Publication type:
- Article
Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e9, doi. 10.1111/bjh.17998
- By:
- Publication type:
- Article
Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 110, doi. 10.1111/bjh.18012
- By:
- Publication type:
- Article
Doing less, accomplishing more for childhood ALL: response.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 120, doi. 10.1111/bjh.17814
- By:
- Publication type:
- Article
Life‐changing consequences of vaccine‐induced immune‐mediated thrombosis with thrombocytopenia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 121, doi. 10.1111/bjh.18005
- By:
- Publication type:
- Article
The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e12, doi. 10.1111/bjh.17999
- By:
- Publication type:
- Article
Up‐regulation of miR‐130a is related to leg ulcers in sickle cell anaemia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e16, doi. 10.1111/bjh.18018
- By:
- Publication type:
- Article